MYRBETRIQ

MYRBETRIQ

  • 10/15/2012
  • Astellas Pharma
  • Mirabegron 25mg, 50mg; extended-release tablets.
  • Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
XTANDI

XTANDI

  • 9/24/2012
  • Astellas Pharma US, Inc.
  • Enzalutamide 40mg; caps.
  • Treatment of metastatic castration-resistant prostate cancer in patients who have previously received docetaxel.
OMONTYS

OMONTYS

  • 5/28/2012
  • Affymax and Takeda
  • Peginesatide 2mg, 3mg, 4mg, 5mg, 6mg per 0.5mL single-use vial (preservative-free); 1mg, 2mg, 3mg, 4mg, 5mg, 6mg per 0.5mL single-use prefilled syringe (preservative-free); 10mg/mL, 20mg/2mL multiple-use vial (w. preservatives); solution for IV or SC injection.
  • Anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

Sign Up for Free e-newsletters